These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32071730)

  • 41. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
    Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
    Taoutel R; Ezekowitz MD; Chaudhry UA; Weber C; Hassan D; Gracely EJ; Kamareddine MH; Horn BI; Harper GR
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101130. PubMed ID: 36246771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program.
    Perlman A; Horwitz E; Hirsh-Raccah B; Aldouby-Bier G; Fisher Negev T; Hochberg-Klein S; Kalish Y; Muszkat M
    Isr J Health Policy Res; 2019 Feb; 8(1):19. PubMed ID: 30709417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care.
    Delesie M; Ballet A; Hillegeer C; Desteghe L; Dendale P; Heidbuchel H
    Clin Drug Investig; 2022 Sep; 42(9):775-786. PubMed ID: 35986867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
    Chan YH; Chao TF; Chen SW; Lee HF; Yeh YH; Huang YC; Chang SH; Kuo CT; Lip GYH; Chen SA
    Heart Rhythm; 2020 Dec; 17(12):2102-2110. PubMed ID: 32702416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study.
    Vanderstuyft E; Hias J; Hellemans L; Van Aelst L; Tournoy J; Van der Linden LR
    Eur J Hosp Pharm; 2024 Apr; ():. PubMed ID: 38580430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data.
    Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H
    Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
    Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
    J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients.
    Hirsh Raccah B; Rottenstreich A; Zacks N; Matok I; Danenberg HD; Pollak A; Kalish Y
    J Thromb Thrombolysis; 2019 May; 47(4):550-557. PubMed ID: 30689152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.
    Schwartz J; Merrill S; de Leon N; Thompson A; Fang M
    J Hosp Med; 2017 Jul; 12(7):544-550. PubMed ID: 28699943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utilization and prescribing patterns of direct oral anticoagulants.
    Whitworth MM; Haase KK; Fike DS; Bharadwaj RM; Young RB; MacLaughlin EJ
    Int J Gen Med; 2017; 10():87-94. PubMed ID: 28331354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis.
    Fava JP; Starr KM; Ratz D; Clemente JL
    Ther Adv Drug Saf; 2018 Aug; 9(8):405-414. PubMed ID: 30364869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation.
    Perreault S; Dragomir A; Côté R; Lenglet A; de Denus S; Dorais M; White-Guay B; Brophy J; Schnitzer ME; Dubé MP; Tardif JC
    Front Pharmacol; 2021; 12():812018. PubMed ID: 35095525
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation.
    van der Horst SFB; de Vries TAC; Chu G; Bavalia R; Xiong H; van de Wiel KM; Mulder K; van Ballegooijen H; de Groot JR; Middeldorp S; Klok FA; Hemels MEW; Huisman MV
    TH Open; 2023 Jul; 7(3):e270-e279. PubMed ID: 37772087
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.
    Shrestha S; Baser O; Kwong WJ
    Ann Pharmacother; 2018 Feb; 52(2):147-153. PubMed ID: 28856898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Remaining activity of temporary interrupted direct oral anticoagulants and its impact on intra-ablation heparinization in patients with atrial fibrillation: Comparisons across four drugs and two dose regimens.
    Sairaku A; Onohara Y; Hironobe N; Matsumura H; Kihara Y; Nakano Y
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):1996-2004. PubMed ID: 32459011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.